MSCLF
Price
$0.47
Change
-$0.05 (-9.62%)
Updated
Jul 2 closing price
Capitalization
76.58M
VYGR
Price
$3.20
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
177.08M
26 days until earnings call
Interact to see
Advertisement

MSCLF vs VYGR

Header iconMSCLF vs VYGR Comparison
Open Charts MSCLF vs VYGRBanner chart's image
SATELLOS BIOSCIENCE
Price$0.47
Change-$0.05 (-9.62%)
Volume$177.73K
Capitalization76.58M
Voyager Therapeutics
Price$3.20
Change-$0.00 (-0.00%)
Volume$303.24K
Capitalization177.08M
MSCLF vs VYGR Comparison Chart in %
Loading...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MSCLF vs. VYGR commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCLF is a Hold and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (MSCLF: $0.47 vs. VYGR: $3.20)
Brand notoriety: MSCLF and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSCLF: 205% vs. VYGR: 49%
Market capitalization -- MSCLF: $76.58M vs. VYGR: $177.08M
MSCLF [@Biotechnology] is valued at $76.58M. VYGR’s [@Biotechnology] market capitalization is $177.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSCLF’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • MSCLF’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than MSCLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSCLF’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • MSCLF’s TA Score: 5 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MSCLF is a better buy in the short-term than VYGR.

Price Growth

MSCLF (@Biotechnology) experienced а +5.27% price change this week, while VYGR (@Biotechnology) price change was +7.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($177M) has a higher market cap than MSCLF($76.6M). VYGR has higher P/E ratio than MSCLF: VYGR (6.32) vs MSCLF (2.55). MSCLF YTD gains are higher at: -20.246 vs. VYGR (-43.563). MSCLF has higher annual earnings (EBITDA): -19.92M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. MSCLF (41.2M). VYGR has higher revenues than MSCLF: VYGR (67M) vs MSCLF (0).
MSCLFVYGRMSCLF / VYGR
Capitalization76.6M177M43%
EBITDA-19.92M-97.25M20%
Gain YTD-20.246-43.56346%
P/E Ratio2.556.3240%
Revenue067M-
Total Cash41.2M236M17%
Total DebtN/A42M-
FUNDAMENTALS RATINGS
MSCLF vs VYGR: Fundamental Ratings
MSCLF
VYGR
OUTLOOK RATING
1..100
5011
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5765
P/E GROWTH RATING
1..100
649
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MSCLF's Valuation (33) in the null industry is in the same range as VYGR (34) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

MSCLF's Profit vs Risk Rating (77) in the null industry is in the same range as VYGR (100) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as MSCLF (97) in the null industry. This means that VYGR’s stock grew similarly to MSCLF’s over the last 12 months.

MSCLF's Price Growth Rating (57) in the null industry is in the same range as VYGR (65) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is somewhat better than the same rating for MSCLF (64) in the null industry. This means that VYGR’s stock grew somewhat faster than MSCLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MSCLFVYGR
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISVLF0.210.01
+6.50%
IMPACT Silver Corp.
HBIA73.000.50
+0.69%
Hills Bancorporation
WKGFF0.05N/A
N/A
Westkam Gold Corp.
NISTF19.60-0.07
-0.33%
Nippon Steel Corporation
KWHIY28.73-0.48
-1.64%
Kawasaki Heavy Industries Ltd.

MSCLF and

Correlation & Price change

A.I.dvisor tells us that MSCLF and ATHE have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSCLF and ATHE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSCLF
1D Price
Change %
MSCLF100%
N/A
ATHE - MSCLF
28%
Poorly correlated
+2.64%
AKBLF - MSCLF
28%
Poorly correlated
N/A
VYGR - MSCLF
27%
Poorly correlated
N/A
ABOS - MSCLF
26%
Poorly correlated
+2.65%
PEPG - MSCLF
26%
Poorly correlated
+0.83%
More